Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | B0002 | IM / LA |
| FLU4 | INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 72RF2 | IM / LA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 95BJ9 | IM / RA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | T5757 | IM / LA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | X024650 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 4 | W1C831M | SC / RA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y013579 | SC / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | CX4HL | IM / RA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 95BJ9 | OT |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | T5727 | OT |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X024650 | OT / RA |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y013579 | OT / RA |
no adverse event; incorrect product storage; This spontaneous report was received from an Nurse and refers to a(n) 12-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Historical drugs included Ipol (Polio vaccine inact 3v (Vero)) (IPOL), quadrivalent (Influenza vaccine inact split 4v) (FLUARIX), (Diphtheria vaccine toxoid;Pertussis vaccine acellular 3-component;Tetanus vaccine toxoid)(BOOSTRIX), and COVID-19 vaccine (COVID-19 vaccine). Concomitant therapies were not reported. On 08-Jan-2025, the patient was vaccinated with following vaccines: Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #X024650, expiration date: 31-May-2026) administered by Intramuscular route in Right Arm ; Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013579, expiration date: 03-Feb-2026) administered by Subcutaneous route in Right Arm; (Hepatitis a vaccine inact)(HAVRIX) (lot #T5727) (left arm), administered by Intramuscular route (expiration date was not reported) and Hepatitis b vaccine rHBsAg (yeast))(ENGERIX B) (lot #95BJ9) (right arm), administered by Subcutaneous route (expiration date was not reported). All vaccines were administered for prophylaxis. Patients received improperly stored PROQUAD since it was stored in the refrigerator for months instead of the freezer. The patient experienced no adverse event.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 03/31/2012 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :